Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PPS is up 300% since the switch to Marijuana. Smells like BRILLIANCE to me. Maybe he can receive the Ethical CEO of the Year award for 2016 for what he's done for shareholders.
Idiotic shake attempt....
Nice day, I added more too.
The fact that an attorney will write an opinion suggesting the company is eligible under Rule 144 does not mean that Alpine or COR will clear the stock.
My broker has a list of attorneys that they will not work with. If a cert is presented and the opinion is from one of them, the entire package gets tossed out and the cert is ineligible for deposit.
This company has already "sued itself" using a 3(a)10 rule. You are correct that this situation could occur. I am not well versed with this particular avenue of debt reduction so I am unclear how often they can use this method.
Do you know by any chance?
And does that method apply if the company is/was shell status?
I should have stated that there should not be any Rule 144 exemptions granted to this company as being shell in the past, and not currently SEC Fully Reporting prevents that exemption from registration.
Please reserve judgment on this post until the very last line.
=====================================================================
The official definition of a shell is:
Rule 144(i)(1) defines a shell company as a company± that is now or at any time previously has been an issuer, that has:
(A) No or nominal operations; and
(B) Either:
(1) No or nominal assets;
(2) Assets consisting solely of cash and cash equivalents; or
(3) Assets consisting of any amount of cash and cash equivalents and nominal other assets.
-----------------------------------------------------------------
So lets see.... according to the last financial that has been issued by MBHC it shows the parent company with:
$0 Current Assets
$4001 - Participation in Subsidiary
$303,852 - Due from a "related party"
-------------------------------------------------------------------
With no current assets and only $4000 worth of participation in the subsidiary, this is most definitely a shell. HOWEVER the X factor is the actual Due from a Related Party line.
Unfortunately the financials are unclear when it comes to the Related Party line. They do say that the publicly traded company guaranteed a loan of $101,500 for the software subsidiary, which was settled by the company suing itself in court (3(a)10 proceeding) and settling the debt with 85,000,000 shares. Now the software subsidiary owes the public company that money. Again unfortunately that subsidiary does not exist anymore, making that debt worthless.
---------------------------------------------------------------------
My experience: Between myself and my company I have had nearly 100 certificates deposited in the last 10 years. It has become increasingly difficult to get any Alternative Reporting company deposited, and the regulators are paying very very close attention to the perception of shell status.
In order to prove / disprove shell status an attorney must look back at all financial reports and make sure that there are significant assets or a means to generate revenue. This means from Creation to Present.
Look at the September 2014 and December 2013 filings. They show assets of only $2753 and $5017 respectively. This indicates a shell status, HOWEVER we must now look at income for that period. (Remember shell status definition has an exemption for companies with minimal assets provided they have a means of revenue.)
For the period ending December 31, 2013 there was $841,524 in revenue! Not a shell at that time!
For the 9 months ending September 30, 2014 there was ZERO revenue. Indicating that this was most definitely a shell at that time. No or minimal assets and no or nominal operations.
------------------------------------------------------------------
What that means for us the common shareholder:
THIS MEANS THAT ANYONE STUPID ENOUGH TO HAVE A CONVERTIBLE NOTE WITH THIS COMPANY IS SCREWED!!! A GOOD ATTORNEY OR REGULATOR WILL NOT ALLOW RULE 144 EXEMPTION TO REGISTRATION UNTIL SUCH TIME AS THE COMPANY BECOMES SEC FULLY REPORTING AND MAINTAINS THAT STATUS FOR 1 COMPLETE YEAR!!!!
THIS MEANS THAT WITHOUT AN S-1 REGISTRATION STATEMENT THERE CAN NOT BE ANY DILUTION FROM THIS POINT!!!!!!!!!
--------------------------------------------------------------------
And that's why I'm a long here.
And the others too correct? Not just me as I'm a "new face" here?
Yes but the US economy will plummet, everyone will have taxes increased, and each of our paychecks are likely to decrease by 25% or more.
I'll stick with illegal weed thanks.
I use TDAmeritrade, and by placing, changing, cancelling replacing etc I see that they use a number of different MMs for the same security.
Companies like SpeedTrader used to (not sure if they're even around anymore) let you choose the MM that routed your order, but for the rest, unless you have Level 2 there's no way to tell that I'm aware of.
I've had someone put a larger block on me, and the first hit did not go to me. That part is purely from experience.
To answer your questions:
Does this place you at the front of the line
Also I've placed LARGE buy/sell orders and both bid and ask prices but the size of the bid/ask has not changed. Why is that?
More for me if they are.
Sitting patiently, adding on bid. Looking for a long play here.
INVO Bioscience Receives FDA Clearance for
INVOcell Fertility Treatment
Revolutionary device and procedure provides natural, safe, effective and economical fertility treatment option.
Contact: Kathleen Karloff, CEO
INVO Bioscience, Inc.
978-878-9505 ext. 504
www.invobioscience.com
Medford, MA, November 3 , 2015 – INVO Bioscience, Inc. (OTC Pink: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, today announced that the U.S. Food and Drug Administration (FDA) has granted the Company’s de novo request for the INVOcell™. As a result, INVOcell is the first intravaginal culture system granted marketing clearance in the United States, providing millions of infertile couples across the country access to this revolutionary infertility treatment.
Katie Karloff, chief executive officer of INVO Bioscience, commented, “INVOcell has the ability to significantly transform the way in which fertility clinics across the United States assist infertile patients to achieve their desired outcomes in a simpler, more natural and cost effective manner. It has been a long process to de novo clearance and we are so pleased to have this approval from the FDA to begin marketing and selling in the United States. With this critical approval, we look forward to developing the partnerships necessary to bring this device to millions of patients across the United States.”
In 2012, the World Health Organization (WHO) estimated there are more than 48.5 million couples worldwide that have fertility issues, of which 6.7 million of the couples are in the United States. Less than 10 percent of thee couples who need assistance receive it, making it a substantial untapped market.
The INVOcell is used for the incubation of eggs and sperm during fertilization of early embryo development. Unlike conventional infertility treatments such as in vitro fertilization (IVF), where the eggs and sperm develop into embryos in a laboratory, the INVOcell utilizes the women's vagina as a natural incubator to support embryo development. In clinical studies, the INVOcell procedure produced pregnancy rates equivalent to traditional IVF treatments.
The key features and benefits of the INVOcell device and procedure include:
·
Providing a more natural and stable vaginal incubation than in a conventional IVF incubator;
·
Providing psychological benefits to patients/couples and promoting greater involvement by couples;
·
Reducing the risk of incorrect embryo transfers; and
·
Reducing the cost of infertility treatments and increasing geographic accessibility.
INVOcell has gained national attention over the last year from the infertility community as a safe, effective, and low cost fertility treatment option. During the 2015 American Society of Reproduction Medicine (ASRM) conferences, Dr. Kevin Doody of Bedford, Texas presented results of a randomized 40 patient comparative study demonstrating the INVOcell procedure performed equivalent to that of IVF, with INVOcell producing a 65% pregnancy rate. This presentation also focused on the relative cost reductions that the INVOcell procedure can allow for compared to traditional IVF treatment. As a result of the safety, equivalence of pregnancy rates, and lower overall cost of procedure, ASRM endorsed INVOcell as a viable process for treating infertile patients.
Claude Ranoux, president and founder of INVO Bioscience, commented, “ My goal was to create an alternative treatment to traditional IVF procedures that could produce the desired results in a simpler and more cost effective manner to allow treatment to many more infertile couples. I believe the INVOcell procedure has the ability to significantly transform the way in which infertile couples go about achieving pregnancy. It is my hope that years from now it becomes the gold standard of use throughout the United States and the world. Based on current patient acceptance I think we are on the right track.”
Lori Kahler, managing director of The RC Insight Group who was instrumental in the company achieving this milestone stated, “I am thrilled to see this state-of-the-art technology available in the United States. For couples struggling with infertility, INVOcell is game changing and offers benefits that are unobtainable with traditional IVF. It is rare when a company’s innovation is truly disruptive to an industry, yet INVO Bioscience’s vision and dedication to the treatment of infertility did just that, and now couples have access to affordable and accessible treatment.”
Another study by Dr. Elkin Lucena and his team at the Colombian Fertility and Sterility Center (CECOLFES) in Bogota showed that INVOcell vaginal embryo culture is effective for couples with male factor infertility who use intra-cytoplasmic sperm injection (ICSI).
Charles Coddington, MD, the 2014 President of ASRM, stated, “These studies show how innovative technology may be able to reduce some of the laboratory costs and lead to wider availability of treatment.”
That's always solid news. If the float is the same as last reported, we will fly. Market cap is a joke.
Found this late, but chomped all I could get at .0002. Look at the specifics on this...
SWHI Security Details
Share Structure
Market Value1 $275,487 a/o Nov 02, 2015
Authorized Shares 15,000,000,000 a/o Jun 30, 2015
Outstanding Shares 1,377,435,528 a/o Jun 30, 2015
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 600,016,108 a/o Apr 30, 2015
Par Value 0.0001
During trading hours an AVG trade means a broker closed his position. So you're absolutely right.
Yeah TDAmeritrade is a pain sometimes. This one is worth calling in though.
With all due respect, although I'm not sure there is any, they did purchase JD less than 2 years ago.
Wow a decade... especially when current management has only been here 3 years.... WOW!
Not YET it doesn't. That does not mean it won't soon. ;)
I think so yes!!!
Can you smelllllllllll what the BAYP's been COOKIN???
Tick Tick Tick BOOOOOOM!!
I'm not going to argue semantics.
1. I have a certificate from XYZZ corporation.
2. I send certificate, documentation, DSRQ, and other forms to BMA Securities.
3. BMA, through affiliates or other firms, gets the certificate deposited in my account for me to sell.
4. In order to sell, I call into a BMA account rep and give instructions.
5. BMA sells the securities and sends me the money.
So, BMA takes certificates and gets them deposited, holds in account and sells upon request. That's the part that matters.
My question is, will BMA lend shares out of my account should someone wish to short?
I never said they were self clearing. We all know that there are only 2 or 3 self clearing firms left. What I said was that BMAK Market Maker is BMA Securities who clears certificates. And they do.
My question is if they allow shares deposited through BMA to be lent to others.
Do you happen to know that answer?
Good point.
Huh. For once you're wrong??
http://www.bmasecurities.com/company/#wedo
Stock Certificate Clearing
BMA is recognized as an industry leader in stock certificate depositing and clearing. With over a decade of experience and multiple clearing arrangements, BMA makes stock certificate clearing a seamless process. We verify all transactions through our compliance team prior to approving and completing the deposit.
Process for Depositing and Clearing Stock Certificates:
Complete the Deposited Securities Questionnaire (DSRQ) Click Here to Download
Upon completion, please fax your completed form to (310) 544-6626 or email the form to bma@bmasecurities.com
There is no fee associated with reviewing a prospective deposit on site
Upon completion of our review, BMA will contact you to complete the transaction
BMAK is BMA Securities right? They clear paper... but are also on bid?? Strange that they would be bidding just above .02. If they wanted to keep their position open they could park at .0001.
I have no relationship with BMA so I do not know if they allow shares to be lent.
That it does. I would guess that the attorney fees alone are in the hundreds of thousands of dollars.
Think about what you just said.... IF THEY HAD MONEY THEY WOULDN'T HAVE HAD TO TAKE OUT THE NOTES IN THE FIRST PLACE.
I wouldn't say crude... maybe simplistic, but it is accurate.
And based on the way today looks so far, they're done. Hopefully that's all for a while.
Yes. KBM put in one today and that was all that is in at that time. They reiterated the idea that most are friendly, with only KBM being buttheads.
With that said, convertible note holders are in it only for money. They want their cash back as quickly and easily as possible, but it's not abnormal for one to play nice IF there is a carrot in it for them.
That's KBM. They asked for shares today apparently. Only had $32,000 left and this eats up about $20,000 of that.
More good news on the Oil and Gas front. Appears that OPEC is starting to feel the squeeze of low oil prices.
As the oil downturn enters its second year, OPEC is finally starting to worry. In a market commentary issued earlier this week, the organization said there were "no quick fixes" for the current low-oil-price environment. This is a concern for it and the entire oil industry, as profitability will remain weak in the short term, while there could be longer-lasting consequences if oil does stay lower for longer.
Short-term pain for producers
Much of OPEC is having a tough time with the oil-price weakness. Several nations are running big budget deficits while Venezuela's economy is in shambles, as the drop in oil prices has taken away the lifeblood of its economy. That's why it is reported to have recently requested an emergency meeting in an effort to coordinate a production cut in an effort to spur oil prices. However, before such a meeting were to take place, it would need other non-OPEC nations, namely Russia, to coordinate a production cut with the group.
Even OPEC's largest member, Saudi Arabia, is feeling the pinch of lower oil prices. It's softening the blow by using its foreign currency reserves as well as its first sovereign debt issuance since 2007 to patch a hole in its budget that has been widening as oil prices continue to remain weak. However, it can't cover that gushing wound forever, as one model predicts that it will run out of cash in its reserve fund by August 2018 at its current burn rate if oil stays around $40 per barrel. Meanwhile, poorer OPEC nations such as Libya, Iraq, and Nigeria could be joining Venezuela in turmoil if oil does stay lower for longer. Clearly, there is a near-term motive for OPEC to act before real damage is done to member nations' finances.
Those shorting here will be VERY VERY sad.
Good! I was able to buy at a much much lower price. Also, with an OS of only 5 million the trading would be horrible. Now we have a better sized float.
um that's what is said. The INDUSTRY is called OIL and GAS. Doesn't mean that both components of the INDUSTRY are suffering.
No praying needed.
Out of curiosity, how long would you guess it takes to complete negotiations and financing for a... say... $30,000,000 gross sales / $10,000,000 profit company? A week? A month? 6 months?
The Q filing is VERY important. SEC rules are such that a deal can not be tendered if the company does not have current reports filed.
Now they are filed.
Sounds to me like Shorty McMarketmaker is VERY nervous. I think we caught them way short and they're not able to cover.